HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.645

Change

-0.02 (-0.17)%

Market Cap

N/A

Volume

1.98K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.31 (+0.89%)

CAD 6.64B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.06 (+0.22%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.02%)

CAD 5.91B
PHYS-U:CA Sprott Physical Gold Trust

+0.26 (+1.17%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.26 (+0.69%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.39 (+0.84%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.29 (+1.10%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 3.24B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.18 (-0.78%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.68% 91% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.68% 91% A- 82% B
Trailing 12 Months  
Capital Gain -1.98% 6% D- 16% F
Dividend Return 3.99% 74% C 61% D-
Total Return 2.00% 9% A- 17% F
Trailing 5 Years  
Capital Gain 4.92% 35% F 43% F
Dividend Return 38.23% 95% A 93% A
Total Return 43.14% 63% D 57% F
Average Annual (5 Year Horizon)  
Capital Gain 3.57% 52% F 45% F
Dividend Return 4.31% 53% F 42% F
Total Return 0.74% 81% B- 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.29% 68% D+ 84% B
Risk Adjusted Return 59.10% 71% C- 68% D+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike